Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Equipment >

ALR Technologies (ALRT)

Add ALRT Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 7/6/2017 8:42:34 AM - Followers: 20 - Board type: Free - Posts Today: 0


ALR Technologies, Inc. (OTCBB: ALRT) is a medical device company providing remote monitoring and care facilitation for patients with chronic diseases. ALRT has developed the FDA-cleared and HIPAA compliant Health-e-Connect System that collects data from blood glucose meters and uploads to a secure website. Trained Facilitators use the System to effect efficiency of care among patients, clinicians and caregivers to improve outcomes and assist health plans to optimize their HEDIS goals. Currently, the company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data.

ALRT received FDA clearance for the HeC system in October, 2011.  Company CEO, Sidney Chan, commented, "We are pleased to reach this milestone and are eager to introduce to market this cross-platform technology. The HeC System represents a breakthrough for clinician/patient communication to enhance disease management and improve health outcomes. The System provides the potential to achieve significant savings to the US healthcare system through enhanced adherence to care plans. In anticipation of the FDA clearance, we have been cultivating relationships with manufacturers of diabetes test supplies and insurance companies to help facilitate a successful launch."

President and COO Lawrence Weinstein added, "Diabetes management represents the initial chronic illness application for HeC and we plan to expand upon that platform in 2012. A first-to-market product, the HeC System bridges gaps in current remote monitoring systems in a manner that is efficient, effective and affordable. We anticipate a strong demand based upon our present relationships with industry leaders. Given the flexibility of the HeC System, the potential is enormous. This FDA clearance is a major stride in our commitment to building long-term shareholder value as there is a wide spectrum of chronic diseases which the HeC platform can be deployed to improve outcomes and contain costs."

Sidney S. Chan, CEO and Chairman

Mr. Chan has been involved in managing ALR Technologies since August 1997. Since then, he has played a pivotal role in the evolution of ALR Technologies into a public company. Mr. Chan has been extensively involved in the company's finances and product development. 

Mr. Chan is an engineer who obtained his Bachelor of Engineering (Mining) degree with the distinction in Mineral Economics from McGill University in 1973.

Larry Weinstein, President and Chief Operating Officer

Mr. Weinstein joined ALRT in July 2010, bringing over 25 years of medical device development and management experience from organizations such as Cordis Corporation, DHD Healthcare and PARI Respiratory Equipment. 

Mr. Weinstein received a Bachelor of Science in Chemical Engineering degree from Rensselaer Polytechnic Institute. He earned both a Master of Science degree in Industrial Engineering and an MBA from the University of Miami.

William S. Smith, Director, Commercial Strategy and External Affairs

William S. Smith has worked at senior levels in the private sector and in government. He has more than a decade of experience in healthcare. He served as Managing Director at NSI, a Washington-based government affairs firm. His clients have included major pharmaceutical and biotechnology companies where Mr. Smith has provided strategic advice on government affairs challenges.

Mr. Smith spent ten years at Pfizer, Inc, where he was Vice President for U.S. Public Affairs and Policy. In that role, Smith was the lead advisor on U.S. policy issues to Pfizer's major commercial businesses in the United States. Smith also ran Pfizer's state government affairs group, one of the largest such groups in corporate America.

Mr. Smith previously worked in government where he was on the staff of two Governors in Massachusetts, was a leadership aide to the Republican Leadership in the U.S. House of Representatives, and was a senior aide in the White House Office of National Drug Control Policy under President George H.W. Bush.

Mr. Smith is a graduate of Georgetown University and has a Masters in Politics from the Catholic University of America.

Jerome P. Hickey, Director of Sales and Marketing

Mr. Hickey was most recently National Account Manager at Medicis Pharmaceutical Company, working with many of the largest healthcare payers in the U.S. Prior to Medicis, Mr. Hickey had extensive experience in sales at Pfizer, Inc., rising from a sales representative to assume such positions as Director of Managed Markets Training and Regional Director of Managed Markets for the New York region, one of Pfizer's most important sales regions. Mr. Hickey was responsible for delivering over 1.4 billion dollars in gross revenue at Pfizer.

Kent Stoneking, Pharm. D., CDE, Director, Diabetes Care Facilitation

Dr. Stoneking is a Certified Diabetes Educator (CDE) who has gained extensive, hands-on experience working with a network of internal medicine and family practice physicians to assist patients with diabetes education and self-management training. He received his Doctor of Pharmacy from the University of Tennessee and is an affiliate member of the American Diabetes Association and the American Pharmacists Association.  Dr. Stoneking is Chair of Pharmacy Practice at Union University School of Pharmacy, Jackson, Tennessee.

Dr. Alfonso Salas, Director

Dr. Salas graduated with distinction from Universidad Metroplitana of Barranquilla, Colombia in 1983 with a Doctor of Medicine degree. He began practicing in Santa Marta, Columbia in rural medical facilities and the opened a private practice in 1984. He then worked as a physician with a number of shipping companies and became Medical Director in the office of the Ministry of Social Security and Labor of Columbia in 1991 doing medical assessments for work related accidents. In 1993 Dr. Salas was appointed Director of a Medical Service Plan of Columbia and with a support staff of more than thirty people, maintained a caseload, provided assessment procedures and referral services to hospitals, clinics, and specialists and organized and monitored clinical trials and clinical research in the pharmaceutical and medical field. Since 1995 Dr. Salas has operated his own business in Vancouver, British Columbia, providing medical based consulting services for corporations with a focus on budgeting, research and medical services.

Kenneth Robulak, Director

From December 14, 1999 to January 31, 2001, Mr. Robulak was a member of the ALRT board of directors and from April 4, 2000 to January 31, 2001 Mr. Robulak was ALRT's chief financial officer, secretary, treasurer and vice president.  Mr. Robulak resigned as an officer and director on January 31, 2001. At the time of his resignation, Mr. Robulak did not have any disagreements with ALRT relating to our operations, policies, or practices. Since August 2005, Mr. Robulak has served as a Director of Belle Harbor Owners Association, a not for profit company in Clearwater Beach, Florida. Since July 2007, Mr. Robulak has worked as a marketing consultant to Teco Metal Products, LLC, a technology based manufacturing Company with operations in Dallas, Texas and Guadalajara, Mexico . Mr. Robulak earned a Bachelor of Commerce degree in finance and marketing and is a Fellow of the Institute of Canadian Bankers.

Diabetes information:

CDC Fact Sheet:

Additional Reading: 

One in 10 Adults to Have Diabetes by 2030 as Cases Surge 90%, Report Says (Bloomberg)
Diabetes forecast to hit one in 10 adults by 2030 (Reuters)
Diabetes News Highlights Global Pandemic and Millions of Dollars Wasted (MarketWatch)
Web Black Market in Diabetic Supplies Costs Government $200m (The Daily Beast)

(More to Come...)



February 04, 2013 - ALR Technologies Letter to Shareholders
January 28, 2013 - ALR Technologies Appoints Dr. Kent Stoneking as Director of Diabetes Care Facilitation
January 22, 2013 - ALR Technologies Releases Video on how ALRT Diabetes Care Facilitators Use the Health-e-Connect System (to Improve Outcomes and HEDIS Scores)
January 14, 2013 - ALR Technologies Releasing a Marketing Video with the Commercial Launch of the Health-e-Connect system for Diabetes Care
January 07, 2013 - ALR Technologies Inc. Announces Director of Sales and Marketing

News Archive:


Effect of Internet Therapeutic Intervention on A1C Levels in Patients With Type 2 Diabetes Treated With Insulin



A complete list of videos for viewing is located at:


Taglich Brothers:  PowerPoint format:


download the PDF file by clicking the image.



Outstanding Shares:  233,977,909
Float:  approximately 109,000,000
Insiders Holdings:  approximately 60%
(information as of Feb. 18, 2013, per Yahoo Finance)


ALR Technologies, Inc.
7400 Beaufont Springs Dr.   Suite 300
Richmond, VA     23225
Tel: 804-554-3500


Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#984   I wish they would tell us what is Celador 07/06/17 08:42:34 AM
#983   Unfortunately, the RS hasn't happened yet. eom7 07/05/17 01:09:36 PM
#982   We are hunting rabbits :) Celador 07/04/17 09:05:36 PM
#981   $ALRT: RS is over..... Shhhhhhhhhhhh makinezmoney 07/03/17 11:14:06 AM
#980   100:1 R/S plus a massive increase in Authorized Yosako 03/23/17 02:08:16 PM
#979   CO filed for a R/S with the NVSOS DaReal 02/07/17 12:01:37 AM
#978   I got this from Blizzard Entertainment. I just Celador 02/04/17 03:31:22 PM
#977   Soon" does not imply any particular date, time, Celador 02/04/17 06:23:09 AM
#976   Should see something soon: eom7 02/01/17 10:01:49 AM
#975   Super thin. A PR drives this back eom7 01/23/17 11:04:40 PM
#974   I have 700k looking to add anything I eom7 01/17/17 10:05:35 PM
#973   Yeah, I got about 900k shares Celador 01/17/17 03:54:34 PM
#972   you still holding shares? eom7 01/17/17 10:03:40 AM
#971   I hope so. Celador 01/16/17 08:50:19 AM
#970   looks like ALRT is finally ready to run... eom7 01/15/17 11:25:45 AM
#969   Thin. eom7 01/13/17 03:12:16 PM
#968   Float 154,306,740 a/o Feb 10, 2015 Verified by Transfer Agent eom7 01/13/17 08:54:03 AM
#967   This one says, .002: eom7 01/13/17 08:39:21 AM
#966   On December 20, 2016, the “ Record Date eom7 01/13/17 08:35:15 AM
#965   I thought the product was a good idea. Celador 04/08/16 08:06:05 PM
#964   OMG !! down 41% ... this is history valleyview 02/26/16 05:56:49 AM
#963   I think you are right. That last quarterly Celador 11/15/15 06:19:31 AM
#962   last post was 1 month ago. This looks valleyview 11/02/15 07:24:53 AM
#961   They should be reporting revenue for the first Celador 09/30/15 07:25:39 PM
#960   Why has this stock been so stagnant? They Celador 09/22/15 08:51:34 AM
#959   Is everyone finished on this one ? valleyview 09/16/15 11:24:49 PM
#958   opened at .0031 ..this really has crashed. Is valleyview 08/08/15 05:55:42 AM
#957   Never mind cdietz 07/22/15 08:18:58 PM
#956   Hmm I wonder if something's cooking. We're almost back cdietz 07/22/15 02:08:20 PM
#955   I have a feeling the big bang will GrandeS 06/17/15 03:03:29 PM
#954   what's happening ? grande is gone ! time valleyview 06/15/15 08:34:53 AM
#953   this really looks finished.. no posts for 1 months. valleyview 06/07/15 08:05:08 AM
#952   You and I both. luckydude777 05/08/15 03:34:38 PM
#951   Great I really had hopes they would keep cdietz 05/08/15 03:33:25 PM
#950   Now 2,000,000,000 A/S. (Check recent filing). luckydude777 05/08/15 02:47:49 PM
#949   There it goes cdietz 04/24/15 01:49:04 PM
#948   Can't get order to fill. I've been all cdietz 04/24/15 12:53:58 PM
#947   ALRT a true beast!! no dilution, super clean -Awaken- 04/23/15 08:54:40 AM
#946   ALRT $$$$ ... COULD SEE .03+ BY FRIDAY..AND halbroke1 04/23/15 01:34:20 AM
#945   I believe it to be a male :) CatPuke 04/22/15 08:36:27 AM
#944   Normally a post like yours would bring me luckydude777 04/21/15 10:57:28 PM
#943   ALRT WILL BE .10+ REAL SOON...A HIDDEN GEM HERE.. halbroke1 04/21/15 01:07:12 PM
#942   While we wait for the share price of luckydude777 04/21/15 11:58:18 AM
#941   Some picked up shares in the .005 to CatPuke 04/21/15 10:37:21 AM
#940   ALRT choooooo choooo money train leaving the station -Awaken- 04/21/15 09:38:27 AM
#939   What is appearing as sells are NOT sells. luckydude777 04/21/15 09:36:38 AM
#938   This should start picking up momentum going forward. luckydude777 04/21/15 09:27:34 AM
#937   hard to understand why some are selling so GrandeS 04/21/15 07:50:53 AM
#936   I surely hope she makes her money back. CatPuke 04/20/15 01:34:06 PM
#935   Going crazy will be when it gets back GrandeS 04/20/15 12:50:00 PM